Emraclidine

CAS No. 2170722-84-4

Emraclidine( CVL-231 )

Catalog No. M28837 CAS No. 2170722-84-4

Emraclidine is a muscarinic M4 receptor positive allosteric modulator and can be used in neurological diseases studies.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 337 In Stock
2MG 179 In Stock
5MG 306 In Stock
10MG 493 In Stock
25MG 882 In Stock
50MG 1172 In Stock
100MG 1553 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Emraclidine
  • Note
    Research use only, not for human use.
  • Brief Description
    Emraclidine is a muscarinic M4 receptor positive allosteric modulator and can be used in neurological diseases studies.
  • Description
    Emraclidine is a muscarinic M4 receptor positive allosteric modulator and can be used in neurological diseases studies.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CVL-231
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    AChR
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2170722-84-4
  • Formula Weight
    390.4
  • Molecular Formula
    C20H21F3N4O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (64.04 mM)
  • SMILES
    Cc1cc(C)nc(C2)c1CN2C(CC(C1)CN1c1cc(C(F)(F)F)ncc1)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tang Y, et al. Effect of Syringopicroside Extracted from Syringa oblata Lindl on the Biofilm Formation of Streptococcus suis. Molecules. 2021 Feb 27;26(5):1295.
molnova catalog
related products
  • VU0453595

    VU0453595 is a M1 positive allosteric modulator (PAM).

  • TMPH

    TMPH is an inhibitor of nAChR and inhibits nAChRs lacking α5, α6, or β3 subunits. TMPH can be used in studies about nAChR dysfunction or neurological disorders.

  • ICL-CCIC-0019

    ICL-CCIC-0019 is an inhibitor of choline kinase alpha (ChoKα). ICL-CCIC-0019 induces G1 arrest, endoplasmic reticulum stress, and apoptosis of cancer cell lines.